Posts classified under: UCLA Cannabinoid

Chuchu Zhang, Ph.D.

Faculty Member

Assistant Professor
Department of Physiology
David Geffen School of Medicine
University of California, Los Angeles

 

Department of Physiology
Center for Health Sciences, 53-320
630 Charles E Young Dr S,
Los Angeles, CA 90095

 

Biography

Chuchu Zhang, Ph.D. is an Assistant Professor in the Department of Physiology in the David Geffen School of Medicine at UCLA. She received her B.S. in Biochemistry from the Hong Kong University of Science and Technology. She then received her Ph.D. in Neuroscience from the University of California, San Francisco, where she worked with Dr. David Julius studying pain-producing toxins from venomous animals. Her work utilized these natural toxins to identify and manipulate pain-related signal transduction machineries in sensory neurons. Afterwards, she carried out her postdoctoral fellowship with Dr. Stephen Liberles at Harvard Medical School, where she started her independent trajectory to study nausea. She focused on a brain structure, the area postrema, which mediates nausea responses to several visceral threats. Her work has uncovered fundamental aspects of the area postrema, including cell types, receptors, and nausea-related neural circuits. The Zhang Lab opens in September 2023 at UCLA.

Jeff Bronstein, M.D., Ph.D.

Faculty Member

Biography

Jeff Bronstein received his bachelor’s degree from the University of California, Berkeley and M.D. and Ph.D. from UCLA as a recipient of the Medical Scientist Training Program Award. He completed a residency in Neurology and fellowship training in Movement Disorders at UCLA. Dr. Bronstein also completed a postdoctoral fellowship in molecular biology before being appointed an Assistant Professor of Neurology. He was later appointed Director of the Movement Disorders Program at UCLA. His interests and expertise include the management of Parkinson’s disease (PD) and other movement disorders, surgical treatment of PD, and developing new therapies for patients. Dr. Bronstein was recently awarded one of 6 National Parkinson’s Disease Centers at the Veterans Administration Medical Center with the goal of furthering research, education and clinical care in the Southwest US. His laboratory studies the cause of PD using cell models and a newly developed zebrafish model. His work supported by the NIH and private foundations. Dr. Bronstein also directs clinical trials in order to develop new therapies for PD that include transplantation and deep brain stimulation. He has received several awards and is widely published in the field.